120 related articles for article (PubMed ID: 7512110)
1. Histologically advanced chronic hepatitis C treated with recombinant alpha-interferon: a randomized placebo-controlled double-blind cross-over study.
Sieck JO; Ellis ME; Alfurayh O; Ali MA; Ali HA; Ayub A; al-Fadda M; Zafar M; Halim M; Bernvil SS
J Hepatol; 1993 Nov; 19(3):418-23. PubMed ID: 7512110
[TBL] [Abstract][Full Text] [Related]
2. Randomized, double-blind, placebo-controlled trial of eight-week course of recombinant alpha-interferon for chronic non-A, non-B hepatitis.
Omata M; Ito Y; Yokosuka O; Imazeki F; Tagawa M; Takano S; Hosoda K; Tada M; Ohto M; Ito K
Dig Dis Sci; 1991 Sep; 36(9):1217-22. PubMed ID: 1654240
[TBL] [Abstract][Full Text] [Related]
3. Polyunsaturated phosphatidyl-choline and interferon alpha for treatment of chronic hepatitis B and C: a multi-center, randomized, double-blind, placebo-controlled trial. Leich Study Group.
Niederau C; Strohmeyer G; Heintges T; Peter K; Göpfert E
Hepatogastroenterology; 1998; 45(21):797-804. PubMed ID: 9684137
[TBL] [Abstract][Full Text] [Related]
4. Treatment of chronic hepatitis C with recombinant interferon alpha in kidney transplant recipients.
Rostaing L; Izopet J; Baron E; Duffaut M; Puel J; Durand D
Transplantation; 1995 May; 59(10):1426-31. PubMed ID: 7770930
[TBL] [Abstract][Full Text] [Related]
5. Treatment of chronic hepatitis C with cirrhosis with recombinant human granulocyte colony-stimulating factor plus recombinant interferon-alpha.
Pardo M; Castillo I; Navas S; Carreño V
J Med Virol; 1995 Apr; 45(4):439-44. PubMed ID: 7545214
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of longterm interferon treatment in chronic liver disease evaluated by sensitive polymerase chain reaction assay for hepatitis C virus RNA.
Yokosuka O; Kato N; Hosoda K; Ito Y; Imazeki F; Ohto M; Omata M
Gut; 1995 Nov; 37(5):721-6. PubMed ID: 8549952
[TBL] [Abstract][Full Text] [Related]
7. Treatment of children with chronic hepatitis C with recombinant interferon-alpha: a pilot study.
Ruiz-Moreno M; Rua MJ; Castillo I; García-Novo MD; Santos M; Navas S; Carreño V
Hepatology; 1992 Oct; 16(4):882-5. PubMed ID: 1328009
[TBL] [Abstract][Full Text] [Related]
8. A randomized, double-blind, placebo-controlled trial of recombinant human alpha-interferon therapy for chronic non-A, non-B (type C) hepatitis.
Di Bisceglie AM; Martin P; Kassianides C; Lisker-Melman M; Goodman Z; Banks SM; Hoofnagle JH
J Hepatol; 1990; 11 Suppl 1():S36-42. PubMed ID: 2127786
[TBL] [Abstract][Full Text] [Related]
9. Chronic hepatitis C in patients with normal or near normal alanine aminotransferase levels: the role of interferon alpha 2b therapy.
Van Thiel DH; Caraceni P; Molloy PJ; Hassanein T; Kania RJ; Gurakar A; Friedlander L
J Hepatol; 1995 Nov; 23(5):503-8. PubMed ID: 8583136
[TBL] [Abstract][Full Text] [Related]
10. Interferon alpha therapy in patients with chronic type C hepatitis: changes of serum ALT, anti-HCV & HCV-RNA.
Cho HJ; Dong SH; Lee MS; Kim HY; Park CK; Yoo JY; Polito A; Quan S; Han JH
Korean J Intern Med; 1992 Jan; 7(1):13-7. PubMed ID: 1282364
[TBL] [Abstract][Full Text] [Related]
11. Randomized controlled trial of recombinant alpha-2a-interferon for chronic hepatitis C. Comparison of alanine aminotransferase normalization versus loss of HCV RNA and anti-HCV IgM.
Douglas DD; Rakela J; Lin HJ; Hollinger FB; Taswell HF; Czaja AJ; Gross JB; Anderson ML; Parent K; Fleming CR
Dig Dis Sci; 1993 Apr; 38(4):601-7. PubMed ID: 8384978
[TBL] [Abstract][Full Text] [Related]
12. Therapy of hepatitis C: consensus interferon trials. Consensus Interferon Study Group.
Keeffe EB; Hollinger FB
Hepatology; 1997 Sep; 26(3 Suppl 1):101S-107S. PubMed ID: 9305673
[TBL] [Abstract][Full Text] [Related]
13. Treatment of chronic hepatitis C with consensus interferon: a multicenter, randomized, controlled trial. Consensus Interferon Study Group.
Tong MJ; Reddy KR; Lee WM; Pockros PJ; Hoefs JC; Keeffe EB; Hollinger FB; Hathcote EJ; White H; Foust RT; Jensen DM; Krawitt EL; Fromm H; Black M; Blatt LM; Klein M; Lubina J
Hepatology; 1997 Sep; 26(3):747-54. PubMed ID: 9303508
[TBL] [Abstract][Full Text] [Related]
14. Treatment of chronic hepatitis C with recombinant interferon alfa. A multicenter randomized, controlled trial.
Davis GL; Balart LA; Schiff ER; Lindsay K; Bodenheimer HC; Perrillo RP; Carey W; Jacobson IM; Payne J; Dienstag JL;
N Engl J Med; 1989 Nov; 321(22):1501-6. PubMed ID: 2509916
[TBL] [Abstract][Full Text] [Related]
15. High sustained response rate and clearance of viremia in chronic hepatitis C after treatment with interferon-alpha 2b for 60 weeks.
Reichard O; Foberg U; Frydén A; Mattsson L; Norkrans G; Sönnerborg A; Wejstål R; Yun ZB; Weiland O
Hepatology; 1994 Feb; 19(2):280-5. PubMed ID: 7507462
[TBL] [Abstract][Full Text] [Related]
16. Recombinant human interferon alfa-2b treatment for acute non-A, non-B hepatitis.
Tassopoulos NC; Koutelou MG; Papatheodoridis G; Polychronaki H; Delladetsima I; Giannikakis T; Todoulos A; Toliopoulos A; Hatzakis A
Gut; 1993; 34(2 Suppl):S130-2. PubMed ID: 7686113
[TBL] [Abstract][Full Text] [Related]
17. High doses of recombinant alpha-interferon or gamma-interferon for chronic hepatitis C: a randomized, controlled trial.
Sáez-Royuela F; Porres JC; Moreno A; Castillo I; Martinez G; Galiana F; Carreño V
Hepatology; 1991 Feb; 13(2):327-31. PubMed ID: 1899852
[TBL] [Abstract][Full Text] [Related]
18. Treatment of chronic non-A, non-B hepatitis with interferon.
Karino Y; Matsushima T; Saga A; Tsuyuguchi M; Miyazaki T; Toyota J
Gastroenterol Jpn; 1991 Jul; 26 Suppl 3():234-8. PubMed ID: 1909272
[TBL] [Abstract][Full Text] [Related]
19. Histological changes of the liver by treatment of chronic non-A, non-B hepatitis with recombinant leukocyte interferon alpha. Comparison with histological changes in chronic hepatitis B.
Omata M; Ito Y; Yokosuka O; Imazeki F; Uchiumi K; Takano S; Hosoda K; Ohto M
Dig Dis Sci; 1989 Mar; 34(3):330-7. PubMed ID: 2493364
[TBL] [Abstract][Full Text] [Related]
20. Interferon therapy for acute posttransfusion non-A, non-B hepatitis: response with respect to anti-hepatitis C virus antibody status.
Ohnishi K; Nomura F; Nakano M
Am J Gastroenterol; 1991 Aug; 86(8):1041-9. PubMed ID: 1650129
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
